Comparative safety and effectiveness of cognitive enhancers for Alzheimer’s dementia: a systematic review and individual patient data network meta-analysis (IPD-NMA)
[sidebar] Commissioned and Funded by: Canadian Institutes of Health Research (CIHR) through the Drug Safety and Effectiveness Network (DSEN)
Share Buttons [span][/span]
[ssba-buttons] [/sidebar] [sidebar-content]- Aims to examine the comparative effectiveness and safety of cognitive enhancers versus placebo or best supportive care by patient characteristics, such as Alzheimer’s dementia severity and sex
- The outputs of this study will provide clinicians, patients and caregivers with tailored evidence to inform their decision-making
Related Projects:
[/sidebar-content]Category : KS Projects
Date : 21 Aug 2020